Edwards Lifesciences Corp
Latest Filing: May 6, 2026 • 25 Total Filings
Total Assets
2026
$13.32B
Total Revenue
2026
$1.65B
Net Income
2026
$380.70M
Operating Cash Flow
2026
$43.80M
YA13X31F3V31L8TMPR58ACTIVE95% match confidenceUS-DE

Identity

Legal Address

C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
WILMINGTON, US-DE
19801 US

Category

GENERAL

Registration

Status
ISSUED
Initial
Nov 14, 2012
Next Renewal
May 27, 2027
Managing LOU
5493001KJTIIGC8Y1R12

Corporate Structure